Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection.

Journal article

Munnur D. et al, (2021), Nat Immunol, 22, 1416 - 1427

Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity.

Journal article

Pinto-Fernandez A. et al, (2021), Br J Cancer, 124, 817 - 830

Comprehensive Landscape of Active Deubiquitinating Enzymes Profiled by Advanced Chemoproteomics.

Journal article

Pinto-Fernández A. et al, (2019), Front Chem, 7